Cite
HARVARD Citation
Abraham, W. et al. (2021). Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes. European heart journal. pp. 700-710. [Online].